BAC BV
BAC BV is an established biotech company providing
the life science industry with unparalleled protein purification technologies for drug manufacture and research. BAC has developed a unique affinity ligand discovery program, using its CaptureSelect® technology, which has proven itself for a wide variety of target biotherapeutic compounds, ranging from antibodies and antibody fragments, recombinant and plasma proteins to even viral particles. BAC’s alliances portfolio stretches from small biotech, mainly using its technology for bench-scale research, to big Pharma using BAC’s affinity ligands for drug manufacturing.
A number of CaptureSelect products are currently in use for production of clinical trial material.
CaptureSelect ligands (single domain antibody fragments) can be developed for almost any purification challenge, and offer numerous advantages such as an increase in overall yield, reduction of process steps and increase in product purity all resulting in lower cost of goods. Next to that, CaptureSelect ligands can be tailored to protect the biopharmaceutical using mild elution conditions.
